Jaya Natarajan

1.8k total citations
44 papers, 1.4k citations indexed

About

Jaya Natarajan is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jaya Natarajan has authored 44 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 9 papers in Cardiology and Cardiovascular Medicine and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jaya Natarajan's work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Cardiac electrophysiology and arrhythmias (8 papers) and Reproductive Health and Contraception (8 papers). Jaya Natarajan is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (12 papers), Cardiac electrophysiology and arrhythmias (8 papers) and Reproductive Health and Contraception (8 papers). Jaya Natarajan collaborates with scholars based in United States, Belgium and Germany. Jaya Natarajan's co-authors include Frankie A. Wong, Andrew Chow, R. Rex Williams, Shuchean Chien, Larry S. Abrams, Donna Skee, Mark Rogge, Sue Sha, David Polidori and Paul Rothenberg and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Fertility and Sterility and Epilepsia.

In The Last Decade

Jaya Natarajan

42 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaya Natarajan United States 19 567 345 311 242 209 44 1.4k
Thomas G. Wells United States 24 325 0.6× 198 0.6× 186 0.6× 66 0.3× 92 0.4× 66 1.4k
F Vauzelle-Kervroëdan France 17 258 0.5× 399 1.2× 123 0.4× 110 0.5× 104 0.5× 38 1.3k
Shuchean Chien United States 12 455 0.8× 305 0.9× 239 0.8× 197 0.8× 29 0.1× 14 896
Edith Lackner Austria 19 442 0.8× 232 0.7× 66 0.2× 167 0.7× 64 0.3× 46 1.4k
Reinier M. van Hest Netherlands 24 469 0.8× 405 1.2× 43 0.1× 152 0.6× 114 0.5× 83 1.9k
Peter Krüger Australia 24 405 0.7× 748 2.2× 100 0.3× 172 0.7× 95 0.5× 71 1.9k
R. Lins Belgium 25 282 0.5× 326 0.9× 552 1.8× 76 0.3× 55 0.3× 64 2.6k
Lee B. Barradell 18 323 0.6× 257 0.7× 64 0.2× 155 0.6× 129 0.6× 24 1.3k
Patrick M. Honoré Belgium 33 344 0.6× 1.2k 3.5× 87 0.3× 257 1.1× 88 0.4× 173 3.5k
I. Nilsson-Ehle Sweden 24 865 1.5× 357 1.0× 37 0.1× 318 1.3× 126 0.6× 58 1.8k

Countries citing papers authored by Jaya Natarajan

Since Specialization
Citations

This map shows the geographic impact of Jaya Natarajan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaya Natarajan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaya Natarajan more than expected).

Fields of papers citing papers by Jaya Natarajan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaya Natarajan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaya Natarajan. The network helps show where Jaya Natarajan may publish in the future.

Co-authorship network of co-authors of Jaya Natarajan

This figure shows the co-authorship network connecting the top 25 collaborators of Jaya Natarajan. A scholar is included among the top collaborators of Jaya Natarajan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaya Natarajan. Jaya Natarajan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ouwerkerk‐Mahadevan, Sivi, Italo Poggesi, Eva Vets, et al.. (2025). A Randomized Trial on the Combined Effect of Ponesimod and Propranolol on Heart Rate, Cardiac Safety, and Pharmacokinetics in Healthy Adults. Clinical and Translational Science. 18(9). e70341–e70341. 1 indexed citations
2.
3.
Massarella, Joseph, et al.. (2018). Tramadol Hydrochloride at Steady State Lacks Clinically Relevant QTc Interval Increases in Healthy Adults. Clinical Pharmacology in Drug Development. 8(1). 95–106. 11 indexed citations
4.
5.
Polidori, David, Sue Sha, Tim Heise, et al.. (2014). Effect of canagliflozin, a sodium glucose co‐transporter 2 inhibitor, on C‐peptide kinetics. Clinical Pharmacology in Drug Development. 4(1). 12–17. 7 indexed citations
6.
Biewenga, Jeike, et al.. (2014). Absence of QTc prolongation with domperidone: A randomized, double‐blind, placebo‐ and positive‐controlled thorough QT/QTc study in healthy volunteers. Clinical Pharmacology in Drug Development. 4(1). 41–48. 27 indexed citations
7.
Gisclon, L. G., Angela Bowen, Terry O’Reilly, et al.. (2011). Bioequivalence of a Newly Developed 17β-Estradiol Tablet versus an Identical Reference Formulation. Arzneimittelforschung. 50(10). 910–914.
8.
Moore, Kenneth Todd, Gayatri Sathyan, Ute Richarz, Jaya Natarajan, & Joris Vandenbossche. (2011). Randomized 5‐Treatment Crossover Study to Assess the Effects of External Heat on Serum Fentanyl Concentrations During Treatment With Transdermal Fentanyl Systems. The Journal of Clinical Pharmacology. 52(8). 1174–1185. 23 indexed citations
9.
Hough, David, et al.. (2010). Evaluation of the effect of paliperidone extended release and quetiapine on corrected QT intervals. International Clinical Psychopharmacology. 26(1). 25–34. 27 indexed citations
10.
Vaccaro, Nicole, et al.. (2009). Pharmacokinetics, Safety, and Tolerability of Doripenem After 0.5‐, 1‐, and 4‐Hour Infusions in Healthy Volunteers. The Journal of Clinical Pharmacology. 49(7). 798–806. 42 indexed citations
11.
Chakraborty, Abhijit, Jaya Natarajan, Mary Guilfoyle, et al.. (2005). Population Pharmacokinetics of Erythropoietin in Critically Ill Subjects. The Journal of Clinical Pharmacology. 45(2). 193–202. 9 indexed citations
12.
Chien, Shuchean, et al.. (2002). Absence of a pharmacokinetic interaction between digoxin and levofloxacin. Journal of Clinical Pharmacy and Therapeutics. 27(1). 7–12. 6 indexed citations
13.
Abrams, Larry S., Donna Skee, Jaya Natarajan, & Frankie A. Wong. (2002). Pharmacokinetic overview of Ortho Evra™/Evra™. Fertility and Sterility. 77(2 Suppl 2). 3–12. 73 indexed citations
14.
Berry, David J., Frank Besag, Felicity Jane Pool, Jaya Natarajan, & Dennis R. Doose. (2002). Lack of an Effect of Topiramate on Lamotrigine Serum Concentrations. Epilepsia. 43(8). 818–823. 18 indexed citations
15.
Natarajan, Jaya, et al.. (2001). Pharmacokinetics of Norelgestromin and Ethinyl Estradiol Delivered by a Contraceptive Patch (Ortho Evra™/Evra™) under Conditions of Heat, Humidity, and Exercise. The Journal of Clinical Pharmacology. 41(12). 1301–1309. 41 indexed citations
16.
Chow, Andrew, et al.. (2001). Safety and Pharmacokinetics of Multiple 750-Milligram Doses of Intravenous Levofloxacin in Healthy Volunteers. Antimicrobial Agents and Chemotherapy. 45(7). 2122–2125. 73 indexed citations
17.
Gisclon, L. G., et al.. (2000). Lack of Effect of a High‐Fat Meal on the Bioavailability of 17β‐Estradiol/Norgestimate in Healthy Postmenopausal Women. The Journal of Clinical Pharmacology. 40(7). 762–769. 1 indexed citations
18.
Abrams, Larry S., et al.. (2000). Tetracycline hcl does not affect the pharmacokinetics of a contraceptvie patch. International Journal of Gynecology & Obstetrics. 70(S1). 6 indexed citations
19.
Natarajan, Jaya, et al.. (1997). Expiration Dating of Pharmaceutical Compounds in Relation to Analytical Variation, Degradation Rate, and Matrix Designs. Drug Information Journal. 31(2). 589–595. 14 indexed citations
20.
Anderson, David W., et al.. (1994). Reticulocyte measurements as a bioassay for erythropoietin. Journal of Pharmaceutical and Biomedical Analysis. 12(4). 515–522. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas G. Wells Breakdown of academic impact, for papers by F Vauzelle-Kervroëdan Breakdown of academic impact, for papers by Shuchean Chien Breakdown of academic impact, for papers by Edith Lackner Breakdown of academic impact, for papers by Reinier M. van Hest Breakdown of academic impact, for papers by Peter Krüger Breakdown of academic impact, for papers by R. Lins Breakdown of academic impact, for papers by Lee B. Barradell Breakdown of academic impact, for papers by Patrick M. Honoré Breakdown of academic impact, for papers by I. Nilsson-Ehle
Rankless by CCL
2026